BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8262048)

  • 1. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.
    Halazonetis TD; Kandil AN
    EMBO J; 1993 Dec; 12(13):5057-64. PubMed ID: 8262048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific DNA binding by different classes of human p53 mutants.
    Rolley N; Butcher S; Milner J
    Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.
    Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR
    J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common conformational effects in the p53 protein of vinyl chloride-induced mutations.
    Chen JM; Smith SJ; Marion MJ; Pincus MR; Brandt-Rauf PW
    J Protein Chem; 1999 May; 18(4):467-72. PubMed ID: 10449043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based rescue of common tumor-derived p53 mutants.
    Wieczorek AM; Waterman JL; Waterman MJ; Halazonetis TD
    Nat Med; 1996 Oct; 2(10):1143-6. PubMed ID: 8837616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity.
    Petty TJ; Emamzadah S; Costantino L; Petkova I; Stavridi ES; Saven JG; Vauthey E; Halazonetis TD
    EMBO J; 2011 Jun; 30(11):2167-76. PubMed ID: 21522129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro analysis of the dominant negative effect of p53 mutants.
    Chène P
    J Mol Biol; 1998 Aug; 281(2):205-9. PubMed ID: 9698540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA.
    Klein C; Planker E; Diercks T; Kessler H; Künkele KP; Lang K; Hansen S; Schwaiger M
    J Biol Chem; 2001 Dec; 276(52):49020-7. PubMed ID: 11606582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
    Ethayathulla AS; Nguyen HT; Viadiu H
    J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 protein is an unusually shaped tetramer that binds directly to DNA.
    Friedman PN; Chen X; Bargonetti J; Prives C
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3319-23. PubMed ID: 8475074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.
    Friedler A; Hansson LO; Veprintsev DB; Freund SM; Rippin TM; Nikolova PV; Proctor MR; Rüdiger S; Fersht AR
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):937-42. PubMed ID: 11782540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common conformational effects of p53 mutations.
    Chen JM; Rosal R; Smith S; Pincus MR; Brandt-Rauf PW
    J Protein Chem; 2001 Feb; 20(2):101-5. PubMed ID: 11563689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution.
    Sakamoto H; Lewis MS; Kodama H; Appella E; Sakaguchi K
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8974-8. PubMed ID: 8090755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.
    Thukral SK; Blain GC; Chang KK; Fields S
    Mol Cell Biol; 1994 Dec; 14(12):8315-21. PubMed ID: 7969167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the p53 core domain dimer bound to DNA.
    Ho WC; Fitzgerald MX; Marmorstein R
    J Biol Chem; 2006 Jul; 281(29):20494-502. PubMed ID: 16717092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tetramerization in p53 function.
    Chène P
    Oncogene; 2001 May; 20(21):2611-7. PubMed ID: 11420672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a p53 core tetramer bound to DNA.
    Malecka KA; Ho WC; Marmorstein R
    Oncogene; 2009 Jan; 28(3):325-33. PubMed ID: 18978813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group.
    Hansen S; Hupp TR; Lane DP
    J Biol Chem; 1996 Feb; 271(7):3917-24. PubMed ID: 8632013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.
    Joerger AC; Allen MD; Fersht AR
    J Biol Chem; 2004 Jan; 279(2):1291-6. PubMed ID: 14534297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.
    Srinivasan R; Maxwell SA
    Oncogene; 1996 Jan; 12(1):193-200. PubMed ID: 8552392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.